NewsNov 6, 2025Population Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaPharmacy Times
Press ReleasesNov 6, 2025University Health Network’s Princess Margaret Cancer Centre Partners with Helix to Test 100,000 Patients for Hereditary Risk of Cancer and High Cholesterol
ResearchNov 5, 2025Population Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaAHA | ASA Journals
NewsNov 3, 2025Rochester Regional Health offers free genetic screening to assess cancer and heart disease riskWHEC News 10 NBC
Press ReleasesOct 15, 2025Helix GenoSphere™ Launches MASH-Enriched Cohort of Over 17,000 Linked Clinico-Genomic Records to Accelerate Drug Discovery and Development
Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix GenoSphere™ Launches MASH-Enriched Cohort of Over 17,000 Linked Clinico-Genomic Records to Accelerate Drug Discovery and DevelopmentOctober 15, 2025
Press ReleasesHelix to Present New Population-Scale Genomic Research at ASHG 2025 Annual MeetingOctober 7, 2025
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix GenoSphere™ Launches MASH-Enriched Cohort of Over 17,000 Linked Clinico-Genomic Records to Accelerate Drug Discovery and DevelopmentOctober 15, 2025
Press ReleasesHelix to Present New Population-Scale Genomic Research at ASHG 2025 Annual MeetingOctober 7, 2025
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025